Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau

Alzheimers Dement. 2022 Jan;18(1):116-126. doi: 10.1002/alz.12375. Epub 2021 May 18.

Abstract

Introduction: Apolipoprotein E (APOE) ε4 allele status is associated with amyloid and tau-related pathological changes related to Alzheimer's disease (AD). However, it is unknown whether brain network changes are related to amyloid beta (Aβ) and/or tau-related pathology in cognitively normal APOE ε4 carriers with subthreshold Aβ accumulation.

Methods: Resting state functional connectivity measures of network integrity were evaluated in cognitively normal individuals (n = 121, mean age 76.6 ± 7.8 years, 15% APOE ε4 carriers, 65% female) with minimal Aβ per cerebrospinal fluid (CSF) or amyloid positron emission tomography.

Results: APOE ε4 carriers had increased lateralized connections relative to callosal connections within the default-mode, memory, and salience networks (P = .02), with significant weighting on linear regression toward CSF total tau (P = .03) and CSF phosphorylated tau at codon 181 (P = .03), but not CSF Aβ42 .

Discussion: Cognitively normal APOE ε4 carriers with subthreshold amyloid accumulation may have network reorganization associated with tau.

Keywords: apolipoprotein E; functional connectivity; preclinical Alzheimer's disease; resting state; tau.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / cerebrospinal fluid
  • Amyloid / cerebrospinal fluid
  • Apolipoprotein E4 / genetics*
  • Biomarkers / cerebrospinal fluid
  • Brain
  • Cognition / physiology*
  • Default Mode Network*
  • Female
  • Heterozygote
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Positron-Emission Tomography
  • Prodromal Symptoms*
  • tau Proteins / cerebrospinal fluid*

Substances

  • Amyloid
  • Apolipoprotein E4
  • Biomarkers
  • tau Proteins